Novartis' influenza vaccine Optaflu recommended for EU approval - Forbes.com

Novartis' influenza vaccine Optaflu recommended for EU approval - Forbes.com: "ZURICH (Thomson Financial) - Novartis AG said that the Committee for Medicinal Products for Human Use (CHMP) has recommended European approval for its influenza vaccine Optaflu."